ROBERTO DURAN: Open Payments
NPI 1619915964 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 49 payments from 12 companies in 2025. Trend: 2023 $938 · 2024 $1,150 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $302 |
| ABBVIE INC. | 11 | $171 |
| Amneal Pharmaceuticals LLC | 8 | $135 |
| EMD Serono, Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Biogen, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: NURTEC ODT, CREXONT, QULIPTA, AUSTEDO XR, UBRELVY, JOURNAVX, TYSABRI, Leqembi.
Industry payments across FL — which companies pay providers there.
